Management of decongestant toxicity involves supportive care and symptomatic treatment. In cases of overdose, activated charcoal may be administered to limit absorption, and intravenous fluids may be used to maintain blood pressure. Severe hypertension or arrhythmias may require specific pharmacological interventions. Continuous monitoring and supportive measures are critical to ensure patient recovery.
